Assessment of the anti-norovirus activity in cell culture using the mouse norovirus: Early mechanistic studies
Human norovirus is the main cause of viral gastroenteritis, resulting annually in ∼ 700 million infections and 200,000 deaths, of whom most are children <5 years. Mouse norovirus-infected macrophages are the most widely used in vitro system to screen and characterize the antiviral effect of norov...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2021-09-01
|
Series: | Antiviral Chemistry & Chemotherapy |
Online Access: | https://doi.org/10.1177/20402066211025175 |
id |
doaj-fbd8810ea0c74e17a0abc149299c24f0 |
---|---|
record_format |
Article |
spelling |
doaj-fbd8810ea0c74e17a0abc149299c24f02021-09-16T21:33:32ZengSAGE PublishingAntiviral Chemistry & Chemotherapy2040-20662021-09-012910.1177/20402066211025175Assessment of the anti-norovirus activity in cell culture using the mouse norovirus: Early mechanistic studiesJana Van DyckeJasper RymenantsJohan NeytsJoana Rocha-PereiraHuman norovirus is the main cause of viral gastroenteritis, resulting annually in ∼ 700 million infections and 200,000 deaths, of whom most are children <5 years. Mouse norovirus-infected macrophages are the most widely used in vitro system to screen and characterize the antiviral effect of norovirus-targeting small molecules. We have previously established antiviral assays using this system, identified novel inhibitors and performed additional studies in order to have a first insight into their mechanism of action. After the identification of novel small molecules with anti-norovirus activity (part 1 of this protocol), we here describe the logical next step which entails the generation of early information of their mode of action. This information together with a continuous improvement of the potency of compounds will contribute to the optimization of a compound class towards in vivo efficacy and a successful preclinical development.https://doi.org/10.1177/20402066211025175 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Jana Van Dycke Jasper Rymenants Johan Neyts Joana Rocha-Pereira |
spellingShingle |
Jana Van Dycke Jasper Rymenants Johan Neyts Joana Rocha-Pereira Assessment of the anti-norovirus activity in cell culture using the mouse norovirus: Early mechanistic studies Antiviral Chemistry & Chemotherapy |
author_facet |
Jana Van Dycke Jasper Rymenants Johan Neyts Joana Rocha-Pereira |
author_sort |
Jana Van Dycke |
title |
Assessment of the anti-norovirus activity in cell culture using the mouse norovirus: Early mechanistic studies |
title_short |
Assessment of the anti-norovirus activity in cell culture using the mouse norovirus: Early mechanistic studies |
title_full |
Assessment of the anti-norovirus activity in cell culture using the mouse norovirus: Early mechanistic studies |
title_fullStr |
Assessment of the anti-norovirus activity in cell culture using the mouse norovirus: Early mechanistic studies |
title_full_unstemmed |
Assessment of the anti-norovirus activity in cell culture using the mouse norovirus: Early mechanistic studies |
title_sort |
assessment of the anti-norovirus activity in cell culture using the mouse norovirus: early mechanistic studies |
publisher |
SAGE Publishing |
series |
Antiviral Chemistry & Chemotherapy |
issn |
2040-2066 |
publishDate |
2021-09-01 |
description |
Human norovirus is the main cause of viral gastroenteritis, resulting annually in ∼ 700 million infections and 200,000 deaths, of whom most are children <5 years. Mouse norovirus-infected macrophages are the most widely used in vitro system to screen and characterize the antiviral effect of norovirus-targeting small molecules. We have previously established antiviral assays using this system, identified novel inhibitors and performed additional studies in order to have a first insight into their mechanism of action. After the identification of novel small molecules with anti-norovirus activity (part 1 of this protocol), we here describe the logical next step which entails the generation of early information of their mode of action. This information together with a continuous improvement of the potency of compounds will contribute to the optimization of a compound class towards in vivo efficacy and a successful preclinical development. |
url |
https://doi.org/10.1177/20402066211025175 |
work_keys_str_mv |
AT janavandycke assessmentoftheantinorovirusactivityincellcultureusingthemousenorovirusearlymechanisticstudies AT jasperrymenants assessmentoftheantinorovirusactivityincellcultureusingthemousenorovirusearlymechanisticstudies AT johanneyts assessmentoftheantinorovirusactivityincellcultureusingthemousenorovirusearlymechanisticstudies AT joanarochapereira assessmentoftheantinorovirusactivityincellcultureusingthemousenorovirusearlymechanisticstudies |
_version_ |
1717377950275338240 |